Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07061691 · ClinicalTrials.gov registry record · NA

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

A NA study of Healthy and Stroke, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07061691: Recruiting NA study of Healthy and Stroke, sponsored by Shirley Ryan AbilityLab.

NCT07061691 is a NA study of Healthy and Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07061691, a NA study of Healthy and Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.

Primary Outcome

Primary outcome for Optimization aim of study.

Conditions Studied

Interventions

  • DEVICE WIM Robotic Exoskeleton

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-07-07
Est. Completion 2028-07
Phase NA
Shirley Ryan AbilityLab

138 total trials

What NCT07061691 shows while recruiting

NCT07061691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which WIM Robotic Exoskeleton is the first listed.

NCT07061691 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07061691 about?

NCT07061691 is a clinical study titled "WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity". This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.

What is the current status of trial NCT07061691?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-07. Estimated completion is 2028-07.

What conditions does trial NCT07061691 study?

This clinical trial studies the following conditions: Healthy, Stroke.

What interventions are being tested in trial NCT07061691?

The interventions under investigation include: WIM Robotic Exoskeleton (DEVICE).

Who is sponsoring clinical trial NCT07061691?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07061691 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07061691's enrollment target sits among peer trials

20 861st of 1090 higher than 194 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

  • NCT01630850 · 20 participants · NA

    Islet Transplantation in Patients With "Brittle" Type I Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07061691, the US trial registry maintained by the National Library of Medicine. NCT07061691 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.